EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 10 (2024) SICOT-J, 10 (2024) 46 References
Open Access
Issue
SICOT-J
Volume 10, 2024
Article Number 46
Number of page(s) 6
Section Lower Limb
DOI https://doi.org/10.1051/sicotj/2024043
Published online 08 November 2024
  1. Fanburg-Smith JC, de Pinieux G, Ladanyi M (2020) Mesenchymal chondrosarcoma. In: WHO classification of tumours, 5th edn, soft tissue and bone. The WHO Classification of Tumours Editorial Board, Editors. Lyon, International Arctic Research Center. [Google Scholar]
  2. Wang L, Motoi T, Khanin R, et al. (2012) Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Genes Chromosomes Cancer 51, 127–139. [CrossRef] [PubMed] [Google Scholar]
  3. Dantonello TM, Int-Veen C, Leuschner I, et al. (2008) Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults: experiences of the CWS and COSS study groups. Cancer 112, 2424–2431. [CrossRef] [PubMed] [Google Scholar]
  4. Xu J, Li D, Xie L, et al. (2015) Mesenchymal chondrosarcoma of bone and soft tissue: a systematic review of 107 patients in the past 20 years. PLoS One 10, e0122216. [CrossRef] [PubMed] [Google Scholar]
  5. Frezza AM, Cesari M, Baumhoer D, et al. (2015) Mesenchymal chondrosarcoma: prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society study. Eur J Cancer 51, 374–381. [CrossRef] [PubMed] [Google Scholar]
  6. Schneiderman BA, Kliethermes SA, Nystrom LM (2017) Survival in mesenchymal chondrosarcoma varies based on age and tumor location: a survival analysis of the SEER database. Clin Orthop Relat Res 475, 799–805. [CrossRef] [PubMed] [Google Scholar]
  7. Biermann JS, Chow W, Reed DR, et al. (2017) NCCN guidelines insights: bone cancer, version 2.2017. J Natl Compr Canc Netw 15, 155–167. [CrossRef] [PubMed] [Google Scholar]
  8. Strauss SJ, Frezza AM, Abecassis N, et al. (2021) Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol 32(12), 1520–1536. [CrossRef] [PubMed] [Google Scholar]
  9. Kawaguchi S, Weiss I, Lin PP, et al. (2014) Radiation therapy is associated with fewer recurrences in mesenchymal chondrosarcoma. Clin Orthop Relat Res 472, 856–864. [CrossRef] [PubMed] [Google Scholar]
  10. Ogura K, Higashi T, Kawai A (2017) Statistics of soft-tissue sarcoma in Japan: report from the Bone and Soft Tissue Tumor Registry in Japan. J Orthop Sci 22, 755–764. [CrossRef] [PubMed] [Google Scholar]
  11. Ogura K, Higashi T, Kawai A (2017) Statistics of bone sarcoma in Japan: report from the Bone and Soft Tissue Tumor Registry in Japan. J Orthop Sci 22, 133–143. [CrossRef] [PubMed] [Google Scholar]
  12. Wittekind C, Compton C, Quirke P, et al. (2009) A uniform residual tumor (R) classification: integration of the R classification and the circumferential margin status. Cancer 115, 3483–3488. [CrossRef] [PubMed] [Google Scholar]
  13. Light E, Bridge P (2024) Clinical indications for carbon-ion radiotherapy in the UK: A critical review. Radiography (Lond) 30, 425–430. [CrossRef] [PubMed] [Google Scholar]
  14. Cesari M, Bertoni F, Bacchini P, et al. (2007) Mesenchymal chondrosarcoma. An analysis of patients treated at a single institution. Tumori 93, 423–427. [CrossRef] [PubMed] [Google Scholar]
  15. Tsuda Y, Ogura K, Hakozaki M, et al. (2017) Mesenchymal chondrosarcoma: a Japanese Musculoskeletal Oncology Group (JMOG) study on 57 patients. J Surg Oncol 115, 760–767. [CrossRef] [PubMed] [Google Scholar]
  16. Nakashima Y, Unni KK, Shives TC, et al. (1986) Mesenchymal chondrosarcoma of bone and soft tissue. A review of 111 cases. Cancer 57, 2444–2453. [CrossRef] [PubMed] [Google Scholar]
  17. Strach MC, Grimison PS, Hong A, et al. (2023) Mesenchymal chondrosarcoma: an Australian multi-centre cohort study. Cancer Med 12, 368–378. [CrossRef] [PubMed] [Google Scholar]
  18. Huvos AG, Rosen G, Dabska M, Marcove RC (1983) Mesenchymal chondrosarcoma. A clinicopathologic analysis of 35 patients with emphasis on treatment. Cancer 51, 1230–1237. [CrossRef] [PubMed] [Google Scholar]
  19. Xu B, Rooper LM, Dermawan JK, et al. (2022) Mesenchymal chondrosarcoma of the head and neck with HEY1::NCOA2 fusion: a clinicopathologic and molecular study of 13 cases with emphasis on diagnostic pitfalls. Genes Chromosomes Cancer 61, 670–677. [CrossRef] [PubMed] [Google Scholar]
  20. Morioka H, Takahashi S, Araki N, et al. (2016) Results of sub-analysis of a phase 2 study on trabectedin treatment for extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcoma. BMC Cancer 16, 479. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.